Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer

Author： Losson Hélène Schnekenburger Michael Dicato Mario Diederich Marc

Publisher： MDPI

E-ISSN： 1420-3049|21|11|1608-1608

ISSN： 1420-3049

Source： Molecules, Vol.21, Iss.11, 2016-11, pp. : 1608-1608

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Toxicities of Histone Deacetylase Inhibitors

By Subramanian Srividya Bates Susan E. Wright John J. Espinoza-Delgado Igor Piekarz Richard L.

Pharmaceuticals, Vol. 3, Iss. 9, 2010-08 ,pp. : 2751-2767

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration

By Sleiman Sama F. Berlin Jill Basso Manuela S.Karuppagounder Saravanan Rohr Jürgen Ratan Rajiv R.

Pharmaceuticals, Vol. 4, Iss. 8, 2011-08 ,pp. : 1183-1195

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents

By Mottamal Madhusoodanan Zheng Shilong Huang Tien L. Wang Guangdi

Molecules, Vol. 20, Iss. 3, 2015-03 ,pp. : 3898-3941

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors as Anticancer Drugs

By Eckschlager Tomas Plch Johana Stiborova Marie Hrabeta Jan

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1414-1414

MDPI

Access to resources Recommend Favorite

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

By Bishton Mark J. Johnstone Ricky W. Dickinson Michael Harrison Simon Prince H. Miles

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2674-2688

MDPI

Access to resources Recommend Favorite